Tracking aCAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor-Reference-Cited by-同舟云学术

Tracking aCAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor

Published:2017-06 Issue:6 Volume:28 Page:1302-1308
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Siravegna G.,Sartore-Bianchi A.,Mussolin B.,Cassingena A.,Amatu A.,Novara L.,Buscarino M.,Corti G.,Crisafulli G.,Bartolini A.,Tosi F.,Erlander M.,Di Nicolantonio F.,Siena S.,Bardelli A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/6/1302/17646337/mdx095.pdf

Reference45 articles.

1. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets;Medico;Nat Commun,2015

2. The anaplastic lymphoma kinase in the pathogenesis of cancer;Chiarle;Nat Rev Cancer,2008

3. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology;Hallberg;Nat Rev Cancer,2013

4. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients;Siravegna;Nat Med,2015

5. Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer;Russo;Cancer Discov,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis;npj Precision Oncology;2024-05-13

2. The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer;The Journal of Molecular Diagnostics;2024-04

3. The Potential of Cell-Free DNA in Cancer: towards Standardization and Optimization for Enhanced Diagnosis and Monitoring;J BIOL REG HOMEOS AG;2024

4. Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients;Journal of Cancer Research and Therapeutics;2024-03-08

5. Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review;The Oncologist;2024-02-21